Compare Amphastar Pharmaceuticals Inc (AMPH) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Western Union Co — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.91 (market cap $868.62M), while Western Union Co trades at $7 (market cap $2.20B). The key difference: Western Union Co is far larger — about 2.5× Amphastar Pharmaceuticals Inc's market cap, and Western Union Co pays a 13.33% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | WU | |
|---|---|---|
Market Cap | $868.62M | $2.20B |
Sector | Health | Technology |
52-Week High | $30.81 | $10.28 |
52-Week Low | $16.87 | $6.36 |
Enterprise Value | $1.27B | $2.10B |
Dividend Yield | — | 13.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $19.87, down 2.19% today, with a bullish technical signal from moving averages and ADX indicators. The company reported Q2 2026 EPS of $0.91, beating expectations, but missed in Q4 2025 and Q1 2026. Revenue for 2025 was $719.89M with a net income margin of 10.76%, while valuation ratios like P/E of 12.08 and EV/EBITDA of 6.57 suggest reasonable pricing. Recent news highlights growth from new product launches and ongoing FDA compliance efforts.
The outlook is mixed with growth opportunities from proprietary drugs and biosimilars, but risks include regulatory scrutiny and earnings volatility. Analyst sentiment is cautious with 25% buy ratings, reflecting concerns over execution and market pressures. Investors should weigh solid cash flow generation against competitive and regulatory headwinds for balanced exposure.
Western Union (WU) trades at $6.985, down 0.64% on the day, with a bearish technical signal and recent earnings misses in Q1 and Q2 2026. The company maintains a dividend of $0.24 per share and shows strong profitability with a 9.79% net income margin and 43.97% ROE, but revenue has declined from $4.5B in 2022 to $4.05B in 2025. Analyst consensus is mixed with a $7.14 price target, but news highlights challenges like retail money transfer weakness and strategic shifts.
The outlook is cautious due to declining revenue, earnings volatility, and bearish sentiment, though low valuation ratios (P/E of 5.69) may appeal to value investors. Risks include competitive pressures and execution hurdles in digital transitions, requiring close monitoring of upcoming Q3 earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
